Cellular Senescence Network (SenNet): SenNet Data Coordination, Integration and Organizational Center (U24 or UM1)
ID: 359169Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359169
Timeline
    Description

    The National Institutes of Health (NIH) is announcing a funding opportunity for the Cellular Senescence Network (SenNet) Data Coordination, Integration and Organizational Center (U24 or UM1) as part of its efforts to advance research on cellular senescence and its implications for health and disease. This initiative aims to understand the biological consequences of senescent cell heterogeneity and to develop senotherapeutic strategies by integrating tissue mapping efforts with data to create comprehensive Atlases of Senescence. The program is critical for identifying tissue-specific senescence markers and enhancing health outcomes, with an estimated total funding of $3.4 million and approximately 25 awards expected. Interested applicants can reach out to Ajay Pillai at ajay.pillai3@nih.gov or by phone at 301.538.4811 for further information, with key deadlines including a synopsis post date on September 12, 2025, and a close date on November 13, 2025.

    Point(s) of Contact
    Ajay Pillai Office of Strategic Coordination, DPCPSI, OD
    (301) 538-4811
    ajay.pillai3@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Cellular Senescence Network (SenNet):Technology Projects (UG3/UH3 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for the Cellular Senescence Network (SenNet): Technology Projects (UG3/UH3 Clinical Trial Not Allowed), aimed at small businesses. This initiative seeks to advance understanding of cellular senescence and its implications for health and disease by developing innovative tools and technologies to identify and characterize senescent cells, ultimately facilitating the creation of senotherapeutic strategies. With an estimated total program funding of $6 million and approximately 15 awards anticipated, interested applicants are encouraged to prepare collaborative proposals ahead of the expected application solicitation, which will be published in October 2025, with a closing date in December 2025. For further inquiries, potential applicants can contact Ajay Pillai at ajay.pillai3@nih.gov or by phone at 301-538-4811.
    Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) grant, aimed at supporting large-scale, multidisciplinary research projects focused on aging. This opportunity encourages the formation of collaborative teams that will propose integrated research programs addressing a common hypothesis related to aging, with an emphasis on coordination among various project components. While applications are not currently being solicited, potential applicants are encouraged to prepare meaningful collaborations and responsive projects in anticipation of the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis posting date of March 25, 2026, and a closing date of May 25, 2026. For further inquiries, interested parties can contact the NIA Scientific Contact at niascicontact@mail.nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Facilitating Preclinical and Early Phase Human Studies for New Therapeutics (UG3/UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for facilitating preclinical and early phase human studies for new therapeutics, specifically targeting aging-related conditions. This initiative aims to advance T1 translational aging research, focusing on therapeutics that progress from preclinical stages to first-in-human trials, addressing conditions such as sarcopenia and heart failure with preserved ejection fraction (HFpEF). The funding opportunity, categorized under health-related activities, will utilize the UG3/UH3 Cooperative Agreement mechanism, with an estimated total program funding of $2.5 million. Interested applicants should prepare to submit their applications by fall 2024, with the NOFO expected to be published in summer 2024 and awards anticipated by July 2025.
    Notice of Intent to Publish a Funding Opportunity Announcement for Somatic Cell Genome Editing Translational Coordination and Dissemination Center (U24, Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for the establishment of a Somatic Cell Genome Editing Translational Coordination and Dissemination Center (TCDC) as part of its Somatic Cell Genome Editing (SCGE) program. The objective of this initiative is to accelerate the development of genome editing therapeutic agents by facilitating Investigational New Drug (IND) application enabling studies, establishing regulatory approval pathways, and disseminating successful strategies for initiating first-in-human clinical trials. This funding opportunity is crucial for advancing innovative therapeutic approaches in health, with an estimated total program funding of $2 million and the expectation of one award. Interested applicants can reach out to Dr. Marrah Lachowicz-Scroggins at SCGEprogram@od.nih.gov or by phone at 301-827-8229 for further details, with the anticipated application due dates in Summer 2022 and an estimated award date of April 1, 2023.
    Renewal of NIA Research Centers Collaborative Network (RCCN)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the renewal of the Research Centers Collaborative Network (RCCN), aimed at enhancing collaborations across its seven research centers focused on aging research. This initiative seeks to leverage NIH's significant investments by fostering interdisciplinary efforts and sustaining high-value activities, while also encouraging new initiatives such as pilot funding programs and enhanced mentoring infrastructure. Interested applicants, particularly those with expertise in aging research, are advised to prepare for this opportunity, with the estimated synopsis posting date on March 1, 2026, and a closing date for applications anticipated by May 25, 2026. For further inquiries, potential applicants can contact Amelia Karraker at amelia.karraker@nih.gov or by phone at 301-496-3131.
    Notice of Intent to Publish a Notice of Funding Opportunity for Centers on the Demography and Economics of Aging and Alzheimer�s Disease and Alzheimer�s Disease Related Dementias Coordinating Center (U24 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) intends to publish a Notice of Funding Opportunity (NOFO) for the establishment of a Coordinating Center focused on the Demography and Economics of Aging, including Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD). The objective of this cooperative agreement is to create a hub that facilitates collaboration among various D&E Centers, scholars, and the research community, enhancing the scientific impact and fostering synergies across related programs and infrastructures. This initiative is crucial for promoting an inclusive research environment and raising awareness about the demography and economics of aging. The estimated total program funding is $1,320,000, with an award ceiling of $800,000, and the application process is expected to open in July 2024, with submissions due by October 2024. Interested applicants should prepare to develop meaningful collaborations in advance of the application deadline.
    National Alzheimer’s Coordinating Center (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the establishment of a National Alzheimer's Coordinating Center (NACC) under a cooperative agreement. The NACC aims to serve as a national data resource for Alzheimer's disease and related dementias (AD/ADRD) research, facilitating data collection from Alzheimer’s Disease Research Centers (ADRCs) and enhancing communication within the ADRC program. This initiative is crucial for advancing research in the field of aging and dementia, providing a centralized hub for collaboration and data sharing. Interested small businesses are encouraged to prepare for the application process, with the estimated synopsis posting date on August 15, 2025, and the anticipated award date set for July 15, 2026. For further inquiries, potential applicants can contact Dr. Cerise Elliott at elliottce@nih.gov or by phone at 301-496-9350.
    Forecast for The NINDS Human Biospecimen and Data Repository (U24 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to release a Notice of Funding Opportunity (NOFO) for the NINDS Human Biospecimen and Data Repository, aimed at advancing research in neurological disorders. This initiative will establish a repository to maintain and expand a collection of biospecimens, which will be made available to qualified academic and industry researchers to support basic, translational, and clinical research efforts. The total estimated funding for this program is $1,950,000, with one award anticipated, and interested applicants are encouraged to begin forming collaborations and developing proposals ahead of the expected synopsis posting on August 25, 2025. For further inquiries, potential applicants can contact Dr. Rebecca Price at rebecca.price@nih.gov or by phone at 301-827-3587.
    Notice of Intent to Publish a Notice of Funding Opportunity for Coordination Center for the Alzheimer�s Disease Sequencing Project Consortium (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Coordination Center for the Alzheimer’s Disease Sequencing Project Consortium, aimed at advancing research in Alzheimer's disease genetics. This initiative, which follows the approval of the concept by the National Advisory Council on Aging, will invite applications under an open competition framework, expanding eligibility for potential applicants. The funding opportunity is critical for fostering collaborations and innovative projects in the field of health, with an estimated total program funding of $1.6 million and a maximum award ceiling of $1 million for the selected applicant. The NOFO is expected to be published in November 2024, with applications due by February 14, 2025, and awards anticipated to be made by September 1, 2025.
    Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the establishment of a Data Coordinating Center dedicated to the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA). This initiative aims to integrate and disseminate multiscale mouse brain datasets to support the aging and Alzheimer’s disease research community, leveraging the NIA-supported AD Knowledge Portal for data hosting and collaborative analyses, while also developing tools for the integration of multi-omics and connectomics datasets. The opportunity is particularly significant as it will serve as a central resource for researchers, enhancing the accessibility and visualization of integrated data. Interested applicants, particularly small businesses with expertise in aging research, are encouraged to prepare for the application process, with the estimated synopsis post date set for September 1, 2025, and the application deadline anticipated for January 25, 2026. For further inquiries, potential applicants can contact Erin E. Gray, Ph.D., at erin.gray@nih.gov or by phone at 301-451-3968.